$1.51 Billion is the total value of ARMISTICE CAPITAL, LLC's 66 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 152.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | New | ISHARES TRput | $90,804,000 | – | 6,000 | +100.0% | 6.02% | – |
| CERC | Buy | CERECOR INC | $68,048,000 | -32.1% | 20,683,233 | +12.2% | 4.51% | -28.7% |
| CELG | Buy | CELGENE CORP | $50,842,000 | +37.5% | 512,000 | +28.0% | 3.37% | +44.6% |
| EPC | New | EDGEWELL PERS CARE COcall | $48,735,000 | – | 15,000 | +100.0% | 3.23% | – |
| VNDA | Buy | VANDA PHARMACEUTICALS INC | $47,117,000 | +5.9% | 3,548,000 | +12.3% | 3.12% | +11.3% |
| AMAG | Buy | AMAG PHARMACEUTICALS INC | $46,893,000 | +23.5% | 4,060,000 | +6.8% | 3.11% | +29.9% |
| KHC | New | KRAFT HEINZ CO | $41,903,000 | – | 1,500,000 | +100.0% | 2.78% | – |
| REGN | Buy | REGENERON PHARMACEUTICALS | $41,055,000 | +5.8% | 148,000 | +19.4% | 2.72% | +11.2% |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $34,846,000 | +8.7% | 580,000 | +52.6% | 2.31% | +14.3% |
| BIIB | Buy | BIOGEN INC | $34,457,000 | +426.2% | 148,000 | +428.6% | 2.28% | +453.0% |
| INCY | Buy | INCYTE CORP | $31,770,000 | +64.0% | 428,000 | +87.7% | 2.11% | +72.5% |
| ORLY | New | O REILLY AUTOMOTIVE INC NEW | $26,899,000 | – | 67,500 | +100.0% | 1.78% | – |
| FL | Buy | FOOT LOCKER INC | $26,543,000 | +322.1% | 615,000 | +310.0% | 1.76% | +344.2% |
| DPLO | Buy | DIPLOMAT PHARMACY INC | $26,460,000 | +35.8% | 5,400,000 | +68.8% | 1.75% | +42.7% |
| LULU | Buy | LULULEMON ATHLETICA INC | $25,992,000 | +167.1% | 135,000 | +150.0% | 1.72% | +181.1% |
| TGT | Buy | TARGET CORP | $25,658,000 | +218.5% | 240,000 | +158.1% | 1.70% | +234.6% |
| VFC | New | V F CORP | $25,362,000 | – | 285,000 | +100.0% | 1.68% | – |
| CMG | New | CHIPOTLE MEXICAN GRILL INC | $25,214,000 | – | 30,000 | +100.0% | 1.67% | – |
| ASMB | Buy | ASSEMBLY BIOSCIENCES INC | $24,260,000 | -10.1% | 2,468,000 | +23.4% | 1.61% | -5.5% |
| ONCE | Buy | SPARK THERAPEUTICS INC | $24,245,000 | +248.2% | 250,000 | +267.6% | 1.61% | +266.1% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $24,114,000 | +244.2% | 578,000 | +261.2% | 1.60% | +261.5% |
| RL | New | RALPH LAUREN CORPcl a | $22,149,000 | – | 232,000 | +100.0% | 1.47% | – |
| DBX | Buy | DROPBOX INCcl a | $20,170,000 | -15.2% | 1,000,000 | +5.3% | 1.34% | -10.9% |
| WEN | New | WENDYS CO | $19,980,000 | – | 1,000,000 | +100.0% | 1.32% | – |
| UNH | New | UNITEDHEALTH GROUP INC | $19,124,000 | – | 88,000 | +100.0% | 1.27% | – |
| VYGR | Buy | VOYAGER THERAPEUTICS INC | $18,862,000 | -26.0% | 1,096,000 | +17.1% | 1.25% | -22.2% |
| BOLD | New | AUDENTES THERAPEUTICS INC | $17,865,000 | – | 636,000 | +100.0% | 1.18% | – |
| WING | New | WINGSTOP INC | $12,917,000 | – | 148,000 | +100.0% | 0.86% | – |
| ULTA | New | ULTA BEAUTY INC | $11,655,000 | – | 46,500 | +100.0% | 0.77% | – |
| MRK | New | MERCK & CO INC | $11,448,000 | – | 136,000 | +100.0% | 0.76% | – |
| CRSP | New | CRISPR THERAPEUTICS AGnamen akt | $10,821,000 | – | 264,000 | +100.0% | 0.72% | – |
| TSCO | New | TRACTOR SUPPLY CO | $9,768,000 | – | 108,000 | +100.0% | 0.65% | – |
| VXRT | New | VAXART INC | $8,616,000 | – | 24,000,000 | +100.0% | 0.57% | – |
| EYEG | New | EYEGATE PHARMACEUTICALS INC | $8,438,000 | – | 1,792,500 | +100.0% | 0.56% | – |
| TWNK | New | HOSTESS BRANDS INCcl a | $8,111,000 | – | 580,000 | +100.0% | 0.54% | – |
| LB | New | L BRANDS INC | $8,032,000 | – | 410,000 | +100.0% | 0.53% | – |
| AYTU | Buy | AYTU BIOSCIENCE INC | $6,195,000 | +63.9% | 5,120,064 | +156.0% | 0.41% | +72.7% |
| AVYA | New | AVAYA HLDGS CORP | $5,320,000 | – | 520,000 | +100.0% | 0.35% | – |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $5,083,000 | – | 30,000 | +100.0% | 0.34% | – |
| URBN | New | URBAN OUTFITTERS INC | $4,775,000 | – | 170,000 | +100.0% | 0.32% | – |
| PTCT | New | PTC THERAPEUTICS INC | $4,600,000 | – | 136,000 | +100.0% | 0.30% | – |
| ALIM | Buy | ALIMERA SCIENCES INC | $3,362,000 | -35.3% | 5,936,000 | +1.7% | 0.22% | -31.8% |
| CPST | New | CAPSTONE TURBINE CORP | $2,670,000 | – | 835,000 | +100.0% | 0.18% | – |
| CTXR | New | CITIUS PHARMACEUTICALS INC | $2,468,000 | – | 2,197,385 | +100.0% | 0.16% | – |
| SPHS | New | SOPHIRIS BIO INC | $2,207,000 | – | 1,793,666 | +100.0% | 0.15% | – |
| BLCM | New | BELLICUM PHARMACEUTICALS INC | $1,087,000 | – | 1,034,962 | +100.0% | 0.07% | – |
| MDGS | New | MEDIGUS LTDsponsored ads | $809,000 | – | 1,285,715 | +100.0% | 0.05% | – |
| AEZS | New | AETERNA ZENTARIS INC | $494,000 | – | 480,000 | +100.0% | 0.03% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
| SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
| MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
| VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
| REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
| ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
| ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
| INCYTE CORP | 21 | Q3 2023 | 2.8% |
| VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
| BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
| Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
| Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
| Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
| Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
| BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
| Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
| Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.